 | Up a level |
Jeremić, Branislav; Casas, Francesc; Dubinsky, Pavol; Gomez-Caamano, Antonio; Cihoric, Nikola; Videtic, Gregory; Igrutinovic, Ivan (2018). Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer. Frontiers in oncology, 8(30), p. 30. Frontiers Research Foundation 10.3389/fonc.2018.00030
Jeremic, Branislav; Casas, Francesc; Dubinsky, Pavol; Gomez-Caamano, Antonio; Cihoric, Nikola; Videtic, Gregory; Latinovic, Miroslav (2017). Combined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence? Journal of radiation research, 58(3), pp. 267-272. Oxford University Press 10.1093/jrr/rrx003
Jeremić, Branislav; Casas, Francesc; Dubinsky, Pavol; Gomez-Caamano, Antonio; Cihoric, Nikola; Videtic, Greg (2016). Surgery for Stage IIIA Non-Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It. Clinical lung cancer, 17(2), pp. 107-112. Elsevier 10.1016/j.cllc.2015.11.001
Jeremic, Branislav; Cihoric, Nikola; Casas, Francesc; Gomez-Caamaño, Antonio; Dubinsky, Pavol (2016). No Role For Trimodality Therapy and Consolidation Chemotherapy Compared With Concurrent Radiochemotherapy Alone in Stage III Non-Small-Cell Lung Cancer. Journal of clinical oncology, 34(2), pp. 196-197. American Society of Clinical Oncology 10.1200/JCO.2015.63.5037
Jeremic, Branislav; Casas, Francesc; Dubinsky, Pavol; Cihoric, Nikola; Gomez-Caamano, Antonio (2015). The Trimodality Treatment Approach in Stage III/pN2 Non-Small Cell Lung Cancer: "Usually Appropriate" May Well be a Very Inappropriate Treatment Option. American journal of clinical oncology, 38(6), p. 645. Lippincott, Williams & Wilkins 10.1097/COC.0000000000000223
